Search for: "SUN PHARMACEUTICAL INDUSTRIES, INC."
Results 61 - 80
of 123
Sort by Relevance
|
Sort by Date
14 Sep 2010, 10:27 am
\ Author Robert Elliott, executive vice president, Amaxx Risks Solutions, Inc. has worked successfully for 20 years with many industries to reduce Workers’ Compensation costs, including airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality and manufacturing. [read post]
18 Aug 2010, 12:19 am
Caraco Pharmaceutical Labs and Sun Pharmaceutical Ind. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
4 Aug 2010, 12:21 am
Taro Pharmaceutical Industries Ltd. et al. [read post]
28 Jul 2010, 2:32 pm
Sun Pharmaceutical Industries, Ltd. v. [read post]
21 Jul 2010, 5:31 pm
\ Author Robert Elliott, executive vice president, Amaxx Risks Solutions, Inc. has worked successfully for 20 years with many industries to reduce Workers’ Compensation costs, including airlines, healthcare, printing/publishing, pharmaceuticals, retail, hospitality and manufacturing. [read post]
14 Jul 2010, 6:47 pm
Sun Pharmaceutical Industries, Inc. [read post]
11 Jul 2010, 8:33 pm
Environmental Protection Agency announced that Monsanto Company Inc., of St. [read post]
16 Jun 2010, 3:02 pm
Sun Pharmaceutical Industries Ltd. et al. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals Industries Ltd. et al. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
25 Jan 2010, 5:00 am
See Basic, Inc. v. [read post]
23 Jan 2010, 6:53 pm
The first agreement was with Hologic Inc., a Bedford, Mass. [read post]
1 Dec 2009, 9:45 am
Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE and Caraco Pharmaceutical Laboratories Ltd. [read post]
18 Nov 2009, 4:57 am
Sun Pharmaceutical Industries Ltd. et al. [read post]
18 Nov 2009, 4:57 am
Sun Pharmaceutical Industries Ltd. et al. [read post]
18 Nov 2009, 4:57 am
Sun Pharmaceutical Industries Ltd. et al. [read post]
31 Oct 2009, 4:06 pm
Environmental Protection Agency Region 5 has reached an agreement with Sunoco Inc. [read post]
21 Oct 2009, 6:13 am
In re KGK Synergize (non precedential) (Patently-O) US: Myriad sticks to its business model despite legal action brought by PUBPAT and others: Association for Molecular Pathology v USPTO (Patent Docs) US: Amazing race: Win $250,000 for commercialising biomedical research (Patent Baristas) US: BIO survey on technology transfer shows complexity of university-industry relationships (PatentBIOtech) Products Adderall (Dextroamphetamine, Amphetamine) – US: Shire announces… [read post]
